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 Abstract: Employing ensemble Protein-Ligand Interaction Fingerprints (ensPLIF) as 
descriptors in post retrospective Structure-Based Virtual Screening (SBVS) campaigns 
Quantitative Structure-Activity Relationship (QSAR) analysis has been proven to 
significantly increase the predictive ability in the identification of potent ligands for 
estrogen receptor alpha (ERα). In the research presented in this article, similar approaches 
have been performed to construct and retrospectively validate an SBVS protocol to 
identify marginal ligands for ERα. Based on both validated SBVS protocols, a graphical-
user-interface (GUI) application to identify if a compound is a non-, moderate or potent 
ligand for ERα was developed. The GUI application was subsequently used to virtually 
screen genistin, genistein, daidzin, and daidzein, followed by in vitro test employing a 
cytotoxic assay using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide 
(MTT) method. 
Keywords: Ensemble Protein-Ligand Interaction Fingerprints; Structure-Based Virtual 
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■ INTRODUCTION 
Binary Quantitative Structure-Activity Relationship 
(QSAR) analysis of results from retrospective Structure-
Based Virtual Screening (SBVS) campaigns could increase 
the prediction quality of the SBVS protocols [1-5]. The 
use of binary QSAR in SBVS was started with the 
successful attempt by [2] to increase the predictive ability 
of SBVS protocol to identify potent ligands for estrogen 
receptor alpha (ERα) [6-7]. Since then, the SBVS 
protocols using binary QSAR analysis incorporated in 
SBVS campaigns to identify marginal and potent ligands 
for cyclooxygenase-2 (COX-2) were developed with 
excellent predictive ability in retrospective studies using 
ligands and decoys collected by the enhanced version of 
Database of Useful Decoys (DUD-E) [4-5,7]. Notably, by 
employing ensemble Protein-Ligand Interaction 
Fingerprints (ensPLIF) as a newly introduced descriptor 
in binary QSAR analysis resulted from retrospective 
SBVS campaigns targeting ERα, the F-measure value [8] 
as the objective function of the predictive ability of the 
SBVS protocol could reach 0.769 [3], which was 
significantly higher compared to the original SBVS 
protocol (F-measure value = 0.181) [7]. Moreover, a 
similar method using ensPLIF was also successfully 
employed in the design of lead compounds for the 
discovery of acetylcholinesterase inhibitors [9]. 
The development of highly predictive SBVS 
protocols to identify ligands for ERα has started in the 
design of eugenol analogs as ligands for ERα [10]. 
Database of Useful Decoys [11] was used to 
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retrospectively validate the SBVS protocol. Inspired by 
[12], PyPLIF was developed [13] and the results of the 
retrospective SBVS campaign [10] were employed to 
validate the ability of the software in increasing the 
predictive ability [14]. The SBVS protocol using PyPLIF 
[14] was subsequently employed in the discovery of novel 
activity for COX-2 inhibitor celecoxib as a potent ligand 
for ERα [15]. In 2012, DUD-E was publicly available [7]. 
The SBVS protocol was then re-validated [6] and 
combined with binary QSAR analysis using Recursive 
Partitioning and Regression Trees (RPART), which 
fortunately could significantly increase the predictive 
ability with an F-measure value of 0.642 [2,16]. Moreover, 
the recently introduced descriptor ensPLIF in the binary 
QSAR could assist to reach higher predictive ability with 
an F-measure value of 0.769 [3]. 
The potent ligands in DUD-E were defined as active 
ligands with affinities (IC50, EC50, Ki, Kd, and log variants 
thereof) of 1 μM or better, while active ligands with 
affinities above 1 μM were defined as marginal ligands [7]. 
Notably, there are widely known phytochemicals identified 
as marginal ligands for ERα [17-18]. Unfortunately, 
different from COX-2 [5], there is still no SBVS protocol 
to identify marginal ligands for ERα. In this article, the 
development of the SBVS protocol to identify marginal 
ligands is presented. It was started by performing SBVS 
campaigns on marginal ligands for ERα [7]. Together with 
the results from the SBVS campaigns on potent ligands 
for ERα and their decoys [3], the ensPLIF values resulted 
from this research were employed as descriptors in the 
binary QSAR analysis by employing RPART method [3]. 
Together with the previously optimized and validated 
SBVS protocols to identify potent ligands for ERα [3], the 
validated SBVS protocols were then incorporated in a 
graphical-user-interface (GUI) application. The application 
was then employed to virtually screen genistin, genistein, 
daidzin, and daidzein. The results were subsequently 
compared to the results from in vitro tests employing 
cytotoxic assay on T47D cell line using 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide 
(MTT) method [15,19]. 
■ EXPERIMENTAL SECTION 
Materials 
Similar to the retrospective SBVS campaigns on 
potent ligands for ERα [3], the required files to perform 
molecular docking simulations were obtained from [10] 
while the required files to perform PLIF identification 
were obtained from [14]. Those files were plants.config, 
protein.mol2, water.mol2, OHT.mol2, config.txt, and 
ER_site.mol2. The ERα marginal ligands (marginal_ 
actives_nM_chembl.ism) in the SMILES format were 
downloaded from http://dude.docking.org/targets/esr1/. 
The ensPLIF values of potent ligands and decoys were 
obtained from [3]. Retrospective SBVS campaigns on 
marginal ligands for ERα were performed on a Linux 
(Ubuntu 12.04 LTS Precise Pangolin) machine with 
Intel© Xeon™ CPU E31220 (@ 3.10 GHz) as the 
processors and 8.00 GB of RAM using the same 
computational medicinal chemistry software as used by 
[3]: OpenBabel [20], SPORES1.3 [21], PLANTS1.2 [22-
23], PyPLIF [13-14], and packages “rpart” [16] and 
“caret” [24] run inside the R computational statistics 
software version 3.3.0 (R-3.3.0) [25]. The development 
of GUI application was performed on a Linux (Linux 
Mint 18.3 Cinnamon 64-bit) machine with Intel© Dual 
Core™ i5-6200UCPU E31220 (@ 2.30 GHz) as the 
processors and 4.00 GB of RAM using the same software 
to perform SBVS campaigns appended by the following 
software to create a GUI application: Zenity 3.18.1.1 
(http://live.gnome.org/Zenity) and BKChem 0.13.0 
(http://bkchem.zirael.org/). The materials for performing 
the in vitro tests were the same as the materials presented 
in [19]. Genistein, genistin, daidzein, and daidzin as the 
in vitro test compounds were purchased from Sigma-
Aldrich. 
Procedure 
The previously published procedure by [3] was 
adopted to perform retrospective SBVS campaigns on 
ERα marginal ligands [7]. There were 520 marginal 
ligands downloaded from http://dude.docking.org/ 
targets/esr1 [7]. Since there were 10 compounds shown  
 
 
Indones. J. Chem., 2019, 19 (2), 531 - 537   
        
                                                                                                                                                                                                                                             
 
 
Nunung Yuniarti et al.   
 
533 
 
Fig 1. The decision tree adopted from the best classification tree resulted from the RPART method [3,16] 
 
affinity values of more than 500 μM, only the remaining 
510 compounds proceeded to the ligand preparation step. 
The results of these SBVS campaigns were then appended 
to the results of the SBVS campaigns of the potent ligands 
for ERα [3] and encoded as positives (P). The negatives 
(N) were obtained from the results of the SBVS campaigns 
of the decoys for ERα [3]. The binary QSAR models were 
then optimized using ensPLIF values as the descriptors 
[3,9] following the same procedure as published by [3]. 
The EF and F-measure values were then calculated to 
examine the predictive quality of the protocol [3,8]. Based 
on the optimized SBVS protocol to identify potent ERα 
ligands [3] and the optimized SBVS protocol to identify 
ERα marginal ligands, a GUI application was developed 
using BKChem to build the test compound and Zenity to 
display GUI dialogs of the process and the output. The 
developed GUI application was then employed to 
virtually screen genistein, genistin, daidzein, and daidzin. 
The in vitro test procedures were the same as the 
procedures employed by [19] and were performed in the 
Integrated Research and Assessment Laboratory, Gadjah 
Mada University, Yogyakarta. The IC50 values were 
calculated using two parameters logistic regressions in 
R-3.3.0 [15,25-26]. 
■ RESULTS AND DISCUSSION 
Aimed to develop SBVS protocol to identify ERα 
marginal ligands, retrospective SBVS campaigns on ERα 
marginal ligands collected by DUD-E [7] have been 
performed. Combined with the SBVS protocol to 
identify ERα potent ligands [3], this protocol will be 
useful to discover phytoestrogen since, similar to COX-
2, most phytochemicals active as marginal ligands for 
ERα [5,17-18]. In total, together with 20685 decoys as N 
[3,7], there were 889 active ligands as P resulted from 
510 marginal ligands and 379 potent ligands [3,7] went 
further in the SBVS optimization using binary QSAR to 
obtain the optimized decision tree [16] for the SBVS 
protocol. The best SBVS protocol to identify marginal 
ligands for ERα resulted in this research could reach EF 
and F-measure values of 196.759 and 0.751, respectively. 
These values resulted from the following confusion 
matrix: 575 true positives (TP), 314 false negatives (FN), 
20617 true negatives (TN) and 68 false positives (FP). 
Based on the EF and F-measure values, the predictive 
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ability of the SBVS protocol was considered excellent, 
since the values were higher than the values of the SBVS 
protocol to identify ligands for ERα in DUD-E (EF = 15.4; 
F-measure = 0.182) [7]. Moreover, no evidence for chance 
correlation, cross-correlation between descriptors and 
overfitting was found for the optimized SBVS protocol. 
The best decision tree incorporated in the SBVS protocol 
is presented in Fig. 1. 
Equipped with SBVS protocol to identify ERα 
marginal ligands optimized here and the published 
previously SBVS protocol to identify ERα potent ligands 
[3], a GUI application to virtually screen a compound was 
developed. Similar to the availability of a GUI application 
to visualize molecule PyMOL to assist drug design [27], 
the availability of this GUI application was expected to 
efficiently and effectively assist drug design and discovery 
particularly the ones targeting ERα. The shell scripts and 
other components of the GUI application following the 
algorithm presented in Fig. 2 could be obtained from the 
corresponding author or by downloading from the 
following link: http://esr1.molmod.org/iERa0.9.zip. Fig. 3 
presents the short version of the virtual screening of 
genistein using the application. The full version could be 
found in the tutorial of the application. 
 
Fig 2. The algorithm of the application developed in this 
research. a)Obtained from http://bkchem.zirael.org/). 
b)Refer to [20]. c)Refer to [3]. d)See Fig. 1. 
 
Fig 3. Screenshots of BKchem interface, compound identity form and the final report of the virtual screening of 
genistein using the developed application 
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Table 1. The activity of genistein, daidzein, genistin, and daidzin at the ERα 
Compounds 
In silico Testa) In vitro Testb) 
Potent/Marginal Active/Inactive IC50 (μM) Active/Inactive 
 
Potent Active 31.71 Active 
 
Potent Active 14.53 Active 
 
Non Ligand Inactive > 500c) Inactive 
 
Non Ligand Inactive > 500c) Inactive 
a)Results from the GUI application. The compound was considered as active if the results were either potent or marginal; b)Results from 
the cytotoxicity test on T47D cell line using the MTT method. The compound was considered as active if the IC50 ≤ 500 μM; c)The logistic 
regression models were not valid to calculate the IC50 value. By using linear regression models, the extrapolated IC50 values were > 500 μM 
 
The GUI application results showed that genistein 
and daidzein were potent ligands for ERα, while their 
glycosides genistin and daidzin were non-ligand for ERα. 
These results were in line with the in vitro experiments 
using MTT method on T47D cell line (Table 1). The in 
vitro experiments employing immunochemistry method 
to examine the direct effects of genistein and daidzein to 
ERα as well as the development of a web application based 
on the GUI application developed here is still in progress. 
■ CONCLUSION 
The SBVS protocol to identify ERα marginal ligands 
has been optimized to have an excellent predictive ability. 
Together with previously published SBVS protocol to 
identify ERα potent ligands, this SBVS protocol was 
incorporated to a GUI application, which was 
subsequently used to virtually screen genistein, daidzein, 
genistin, and daidzin. The virtual screening results were 
confirmed by the cytotoxicity tests on T47D cell line 
using the MTT method. 
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